Platinum derivatives alone, a reasonable option to treat locally advanced non-small cell lung cancer with chemo-radiotherapy. - Suppr | 超能文献

Platinum derivatives alone, a reasonable option to treat locally advanced non-small cell lung cancer with chemo-radiotherapy.

作者信息

Sanz Rubiales Álvaro, del Valle Rivero María Luisa, Fiorini Talavera Aldo Bruno, Fernández González María

机构信息

Medical Oncology, Hospital Universitario del Río Hortega, Valladolid 47013, Spain.

Radiotherapy, Hospital Clínico Universitario de Valladolid, Valladolid 47001, Spain.

出版信息

Lung Cancer. 2015 Jul;89(1):84-5. doi: 10.1016/j.lungcan.2015.04.013. Epub 2015 May 6.

DOI:10.1016/j.lungcan.2015.04.013

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Platinum derivatives alone, a reasonable option to treat locally advanced non-small cell lung cancer with chemo-radiotherapy.

Lung Cancer. 2015 Jul;89(1):84-5. doi: 10.1016/j.lungcan.2015.04.013. Epub 2015 May 6.

2

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?晚期非小细胞肺癌中铂类与非铂类化疗：顺铂与卡铂有区别吗？

J Clin Oncol. 2005 Sep 1;23(25):6276-7; author reply 6277-8. doi: 10.1200/JCO.2005.02.0156.

3

Role of platinum-based radio-chemotherapy for locally advanced non-small-cell lung cancer: possible influence of type of platinum on survival data.铂类放化疗在局部晚期非小细胞肺癌中的作用：铂类类型对生存数据的可能影响。

Ann Oncol. 2006 Nov;17(11):1724. doi: 10.1093/annonc/mdl130. Epub 2006 Jun 21.

4

Platinums in lung cancer: sufficient or necessary?肺癌中的铂类药物：是充分条件还是必要条件？

J Clin Oncol. 2005 May 1;23(13):2882-3. doi: 10.1200/JCO.2005.11.930. Epub 2005 Feb 22.

5

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer.比较顺铂与卡铂用于晚期非小细胞肺癌患者的随机临床试验的荟萃分析。

J Clin Oncol. 2004 Oct 1;22(19):3852-9. doi: 10.1200/JCO.2004.02.109. Epub 2004 Aug 23.

6

Multimodality management of regionally advanced non-small-cell lung cancer.局部晚期非小细胞肺癌的多模式管理

Semin Oncol. 1993 Aug;20(4):302-14.

7

A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.一项比较以卡铂为基础的化疗与以顺铂为基础的化疗用于晚期非小细胞肺癌的随机对照试验的荟萃分析。

Lung Cancer. 2007 Sep;57(3):348-58. doi: 10.1016/j.lungcan.2007.03.014. Epub 2007 May 7.

8

Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines.晚期非小细胞肺癌的治疗：意大利胸部肿瘤学会（AIOT）临床实践指南。

Lung Cancer. 2011 Jul;73(1):1-10. doi: 10.1016/j.lungcan.2011.02.022. Epub 2011 Mar 25.

9

Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.顺铂与卡铂用于转移性非小细胞肺癌患者——一场旧有的竞争再度展开。

J Natl Cancer Inst. 2007 Jun 6;99(11):828-9. doi: 10.1093/jnci/djk222.

10

Treatment of Locally Advanced Non-Small Cell Lung Cancer.局部晚期非小细胞肺癌的治疗

Hematol Oncol Clin North Am. 2017 Feb;31(1):45-57. doi: 10.1016/j.hoc.2016.08.009.

引用本文的文献

1

Prediction of Overall Survival of Patients with Completely Resected Non-Small Cell Lung Cancer: Analyses of Preoperative Spirometry, Preoperative Blood Tests, and Other Clinicopathological Data.完全切除的非小细胞肺癌患者总生存期的预测：术前肺功能测定、术前血液检查及其他临床病理数据的分析

Cancer Manag Res. 2019 Dec 13;11:10487-10497. doi: 10.2147/CMAR.S232219. eCollection 2019.